Related Experiment Videos
Cymbimicin A and B, two novel cyclophilin-binding structures isolated from actinomycetes
T Fehr1, V F Quesniaux, J J Sanglier
1Novartis Pharma Inc., Preclinical Research, Basel, Switzerland.
The Journal of Antibiotics
|May 21, 1998
Abstract:
Two novel metabolites, cymbimicins A and B, were isolated from the culture broth of a strain of Micromonospora sp. by screening for cyclophilin binding metabolites from actinomycete strains. Cymbimicin A binds to cyclophilin A with a high affinity six fold lower than to that of cyclosporin A. The binding affinity of cymbimicin B is about 100 times lower. The taxonomy of the producing strain, fermentation, isolation, physical and biological properties and structure elucidation are described.